Wei Wang

Wei Wang

University of Houston

H-index: 43

North America-United States

About Wei Wang

Wei Wang, With an exceptional h-index of 43 and a recent h-index of 29 (since 2020), a distinguished researcher at University of Houston, specializes in the field of Cancer Biology, Molecular Pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Substituted bisphenylalkylurea compounds and methods of treating inflammatory conditions

Targeting oncogene and inflammation for cancer therapy

Molecular targeting therapies for neuroblastoma: Progress and challenges

Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope

Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression

Two birds with one stone: NFAT1-MDM2 dual inhibitors for cancer therapy

Targeting MDM2 for novel molecular therapy: Beyond oncology

Wei Wang Information

University

Position

___

Citations(all)

5601

Citations(since 2020)

2557

Cited By

3942

hIndex(all)

43

hIndex(since 2020)

29

i10Index(all)

78

i10Index(since 2020)

64

Email

University Profile Page

University of Houston

Google Scholar

View Google Scholar Profile

Wei Wang Skills & Research Interests

Cancer Biology

Molecular Pharmacology

Top articles of Wei Wang

Title

Journal

Author(s)

Publication Date

Substituted bisphenylalkylurea compounds and methods of treating inflammatory conditions

2023/11/30

Targeting oncogene and inflammation for cancer therapy

Cancer Research

Wei Wang

Sayantap Datta

Sadanandan E Velu

Ming Luo

Ruiwen Zhang

2023/4/4

Molecular targeting therapies for neuroblastoma: Progress and challenges

Atif Zafar

Wei Wang

Gang Liu

Xinjie Wang

Wa Xian

...

2021/3

Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer

European journal of medicinal chemistry

Md Ashraf-Uz-Zaman

Sadisna Shahi

Racheal Akwii

Md Sanaullah Sajib

Mohammad Jodeiri Farshbaf

...

2021/1/1

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope

Atif Zafar

Wei Wang

Gang Liu

Wa Xian

Frank McKeon

...

2021/1/1

Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression

International Journal of Molecular Sciences

Mohammed A Ibrahim Al-Obaide

Viswanath Arutla

Manny D Bacolod

Wei Wang

Ruiwen Zhang

...

2021/3/2

Two birds with one stone: NFAT1-MDM2 dual inhibitors for cancer therapy

Wei Wang

Atif Zafar

Mehrdad Rajaei

Ruiwen Zhang

2020/5/9

Targeting MDM2 for novel molecular therapy: Beyond oncology

Wei Wang

Jiang‐Jiang Qin

Mehrdad Rajaei

Xin Li

Xiaoyi Yu

...

2020/5

Targeting MDM2 for neuroblastoma therapy: in vitro and in vivo anticancer activity and mechanism of action

Cancers

Wei Wang

Xinjie Wang

Mehrdad Rajaei

Ji Youn Youn

Atif Zafar

...

2020/12/5

Targeted brain tumor therapy by inhibiting the MDM2 oncogene: In vitro and in vivo antitumor activity and mechanism of action

Cells

Surendra R Punganuru

Viswanath Arutla

Wei Zhao

Mehrdad Rajaei

Hemantkumar Deokar

...

2020/7/1

See List of Professors in Wei Wang University(University of Houston)